Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

GPCR stock hub

Structure Therapeutics Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

GPCRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.8B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

GPCR

In the news

Latest news · GPCR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-15

P25 -105.6P50 -46.5P75 -3.1

ROIC-12

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All GPCR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

172

Groups with data

Currency

USD

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001888886
Company name	Structure Therapeutics Inc.
Country	United States
Country code	US
Cusip	86366E106
Employees	220
Employees Change	57%
Employees Change Percent	34.97
Enterprise value	$1.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2023-02-03
Isin	US86366E1064
Last refreshed	2026-05-10
Market cap	$2.8B
Market cap category	Mid-Cap
Price	$39.1
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	GPCR
Website	https://structuretx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.13%
P/B ratio	1.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-170.3M
Net Income Growth Years	0%
Profit Per Employee	$-774,259
ROA	-11.57
Roa5y	-21.74
ROCE	-15.15
ROE	-15
Roe5y	-34.78
ROIC	-12.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	47.03%
Cagr3y	18.24%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$1.5B
Cash	$1.5B
Current Assets	$1.5B
Current Liabilities	$57M
Debt	$5.8M
Debt Equity	$0
Equity	$1.4B
Liabilities	$61M
Long Term Assets	$17.5M
Long Term Liabilities	$4M
Net Cash	$1.5B
Net Cash By Market Cap	$52.28
Net Cash Growth	75.17%
Net Debt Equity	$-1
Tangible Book Value	$1.4B
Tangible Book Value Per Share	$20.43
WACC	-3.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	26.16
Net Working Capital	$-22.3M
Quick ratio	25.59
Working Capital	$1.4B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-28.01%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	46.99%
200-day SMA	45.23
3Y total return	65.33%
50-day SMA	50.66
50-day SMA vs 200-day SMA	50over200
All Time High	94.9
All Time High Change	-58.8%
All Time High Date	2025-12-08
All Time Low	13.22
All Time Low Change	195.76%
All Time Low Date	2025-04-09
ATR	2.89
Beta	-1.39
Beta1y	-0.38
Beta2y	1.07
Ch YTD	-43.78
High	39.93
High52	94.9
High52 Date	2025-12-08
High52ch	-58.8%
Low	37.69
Low52	15.8
Low52 Date	2025-08-06
Low52ch	147.47%
Ma50ch	-22.82%
Premarket Change Percent	-1.53
Premarket Price	$38.55
Premarket Volume	8,784
Price vs 200-day SMA	-13.54%
RSI	27.4
RSI Monthly	50.11
RSI Weekly	39.91
Sharpe ratio	0.71x
Sortino ratio	2.22
Total Return	-28.01%
Tr YTD	-43.78
Tr1m	-28.49%
Tr1w	-7.37%
Tr3m	-47.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	12
Analyst Count Top	5
Analyst Price Target Top	$109
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.33
Earnings Revenue Estimate	11,111,110x
Operating Income	$-219.9M
Price target	$103
Price Target Change	$164
Price Target Change Top	$178

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	55,073,420%
Float Percent	77.49%
Shares Insiders	3.55%
Shares Institutions	81.27%
Shares Out	71,071,188
Shares Qo Q	11.74%
Shares Yo Y	28.01%
Short Float	11.16%
Short Ratio	5.37
Short Shares	8.65

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	886,214.3x
Bv Per Share	20.43
Ch1m	-28.49
Ch1w	-7.37
Ch1y	46.99
Ch3m	-47.81
Ch3y	65.33
Ch6m	19.06
Change	-0.13%
Change From Open	2.46
Close	39.15
Days Gap	-2.53
Depreciation Amortization	1,823,500
Dollar Volume	31,401,444.6
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-219.9M
EBITDA	$-218.1M
EPS	$-2.4
F Score	1
Fiscal Year End	December
Founded	2,016
Income Tax	$607,000
Ipr	160.7
Iprfo	56.4
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	53.5
Ma150ch	-26.92%
Ma20	45.86
Ma20ch	-14.74%
Next Earnings Date	2026-08-05
Open	38.16
Optionable	Yes
Position In Range	62.95
Post Close	39.1
Postmarket Change Percent	1.94
Postmarket Price	$39.86
Ppne	11,971,000
Pre Close	39.15
Price Date	2026-05-08
Ptbv Ratio	1.92
Relative Volume	0.91x
Tr6m	19.06%
Us State	California
Volume	803,106

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does GPCR pay a dividend?

Capital-return profile for this ticker.

Performance

GPCR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns GPCR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+81.3%

Float: +77.5% of shares outstanding

Insider ownership

+3.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

GPCR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

27.4

Below 30: short-term oversold

Price vs 200-day MA

-13.5%

50/200-day relationship not available

Beta (5Y)

-1.39

Less volatile than the market

Sharpe ratio

0.71

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About GPCR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current GPCR stock rating?

Structure Therapeutics Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full GPCR analysis?

The full report lives at /stocks/GPCR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for GPCR?

The latest report frames GPCR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the GPCR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.